Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis of Efficacy and Safety

Table 1

Characterization of enrolled trials and extracted data.

Study	Cases (T/C)	Age (years)	Male/female ratio	Outcome indicator
Deng and Li [16]	56/53	1–14	67/43	①②③④⑤
Dou et al. [19]	40/40	2–10	44/36	①
Liu et al. [20]	40/40	2–12	49/31	①②③④⑤
Luo [17]	75/75	0.5–13	85/65	②③④⑤⑥
Ning [21]	60/60	3.9–6.7	74/46	①②③④⑤⑥
Wei [22]	50/50	3–9	46/54	①②③④⑤⑥
Xiao [23]	48/48	1–12	63/33	①②③④⑤⑥
Yang [24]	63/63	2–13	73/53	①②③④⑤⑥
Zuo [25]	51/51	0.5–13	58/44	①⑥

Note: T, therapy group; C, control group; ①, overall response rate; ②, antipyretic time; ③, cough disappearance time; ④, the disappearance time of lung wet Rales; ⑤, hospitalization durations; ⑥, adverse drug reactions.